Royalty Pharma is a leading investment firm specializing in acquiring royalty interests in biopharmaceutical and healthcare products. As a pioneer in the field, the company purchases future revenue streams from intellectual property, providing funding to drug developers in exchange for a share of the product’s sales. This unique financial model allows Royalty Pharma to participate in the success of innovative therapies and contribute to advancements in the healthcare industry.
How to use Business Intelligence from Royalty Pharma
BoldData can deliver 50+ different data fields from Royalty Pharma. From company name to address, revenue, contact data, email data, industry, employees, legal form and founding year. Start your research or sales and marketing campaign to Royalty Pharma or any other industry with our company database of all 310 million companies worldwide in 2,000 industries. The main data sources of our company database are Chamber of Commerces, Financial Reports, Statistics Offices and other public sources in 200+ countries. Ask a quote via the contact form and buy your custom-made list today!
Royalty Pharma Key financial highlights:
- Revenue: Royalty Pharma’s revenue is influenced by the sales performance of the biopharmaceutical and healthcare products in which it holds royalty interests. In previous years, it has reported 2.29 billion U.S. dollars in revenue.
- Profit: The biggest challenge for Royalty Pharma to stay profitable is the success and market performance of the specific drugs in its portfolio, as their sales directly impact royalty payments. Royalty Pharma has historically maintained a considerable net income of 619.8 million U.S. dollars.
- Royalty Pharma’s assets primarily consist of a diversified portfolio of royalty interests in intellectual property related to pharmaceutical and healthcare products. Royalty Pharma has reported 17.52 billion U.S. dollars in assets.
- Royalty Pharma’s market value is determined by the perceived future cash flows from its existing portfolio, potential new acquisitions, and overall market conditions, influencing investor sentiment and demand for its shares in the investment market. Royalty Pharma’s current market value is 18.48 billion U.S. dollars.
Financial data from Royalty Pharma or other companies is available in Excel, Bulk Dataset or API and can be tailored to your needs by our data experts. Ask a quote via the contact form and buy your custom-made list today!
Number of companies owned by Royalty Pharma
Royalty Pharma has 9 subsidiaries in 3 countries. The majority of companies that are owned by Royalty Pharma are based in the United States (6 companies). Second is the United Kingdom with 2 companies in Royalty Pharma’s control (22.2%). Royalty Pharma also owns 1 companies in India.
Company information with group structure from Royalty Pharma or all 300 million companies worldwide is available in Excel, Bulk Dataset or API and can be tailored to your needs by our data experts. Ask a quote via the contact form and buy your custom-made list today!
Buy information from all companies owned by Royalty Pharma
Royalty Pharma’s company information is available in Excel and contains company name, postal address, revenue, number employees, contact information, email address, phone number, website, social media link, founding year, activity, sector and many other data fields. This database of companies owned by Royalty Pharma is therefore suitable for all purposes: from direct marketing to analysis or market research. Do you want to target competitors of Royalty Pharma? BoldData can deliver company information from all 300 million companies worldwide in 2,000 industries. All our company data is verified continuously by automated processes and human eyes. Do you have CRM data in need of enrichment?? Supercharge your data with BoldData’s enrichment services – reach out to us today to ignite your data-driven success!
Outsmart your competition with our comprehensive company data. Delivered in a custom-made Excel sheet, bulk dataset or API. Simply ask us for a quote via the contact form.
